Your browser doesn't support javascript.
loading
Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review.
Shaheen, Nour; Mohamed, Abdelrahman; Attalla, Almoatazbellah; Diab, Rehab Adel; Swed, Sarya; Nashwan, Abdulqadir J; Rababah, Ala' Abdala; Hefnawy, Mahmoud Tarek; Soliman, Youssef; Abdelwahab, Omar Ahmed; Desouki, Mariam Tarek; Khaity, Abdulrhman; Shaheen, Ahmed; Ramadan, Abdelraouf; Meshref, Mostafa.
Afiliação
  • Shaheen N; Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Mohamed A; Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Attalla A; Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Diab RA; Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Medical Research Group of Egypt, Cairo, Egypt.
  • Swed S; Aleppo University, Faculty of Medicine, Aleppo, Syria.
  • Nashwan AJ; Hamad Medical Corporation, Doha, Qatar.
  • Rababah AA; Internal Medicine, King Hussein Medical Center, Amman, Jordan.
  • Hefnawy MT; Faculty of Medicine, Zagazig University, Egypt, Medical Research Group of Egypt, Cairo, Egypt.
  • Soliman Y; Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Abdelwahab OA; Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Medical Research Group of Egypt, Cairo, Egypt.
  • Desouki MT; Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Khaity A; Faculty of Medicine, Elrazi University, Khartoum, Sudan.
  • Shaheen A; Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Ramadan A; Faculty of Medicine, Helwan University, Cairo, Egypt.
  • Meshref M; Neurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Infect Drug Resist ; 15: 6317-6330, 2022.
Article em En | MEDLINE | ID: mdl-36345537
With over 58 million cases and 6 million deaths by August 2022, the Coronavirus disease 2019 (COVID-19), causing severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2), has had an insurmountable impact on the world's population. This is one of the worst health crises since 1918's influenza pandemic. There are four subvariants of Omicron; BA.1, BA.1.1, BA.2 and BA.3. As a result of new mutations in its spike protein, most of which occur in its receptor binding site, the Omicron variant appears to be more transmissible and less resistant to vaccination and antibody response. Understanding Omicron's virology and mutations is essential to developing diagnostic and therapeutic methods. A thorough assessment of control measures, as well as timely adjustment of control measures, requires addressing such issues as re-infection risk, vaccine response, booster vaccine doses, and the increased rate of Omicron infections. This review article aims to look at the current information about the different types of SARs-CoV-2, focusing on the new subtype BA.2.75.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Infect Drug Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Infect Drug Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito